Clear cell renal cancer metabolism: Secrets behind fatty acid synthesis. Preliminary efficacy and safety results of tislelizumab (T) and axitinib (A) combined with stereotactic body radiation therapy ...

An incidental low-density renal mass on non-contrast computed tomography (CT) could actually be an aggressive subtype of papillary renal cell carcinoma (pRCC) but diagnosed as a benign cyst using ...

Brigham and Boston Medical Center researchers found that different types of kidney damage are associated with the chances of developing and dying from heart disease Findings highlight the individual ...

Identifying kidney cancer and differentiating between kidney cancer tumor types with a urine test is still more of a fond wish than a reality, but several strategies that are in late-stage development ...

An international challenge to use artificial intelligence to define the state-of-the-art in kidney and kidney tumor segmentation in CT imaging. This is an ASCO Meeting Abstract from the 2020 ...

Please provide your email address to receive an email when new articles are posted on . A small trial that compared radiofrequency ablation with stereotactic body radiation therapy for small renal ...

Active surveillance offers a conservative yet increasingly validated approach to managing small renal masses. By closely monitoring these lesions through regular imaging and clinical assessments, ...

Please provide your email address to receive an email when new articles are posted on . Study results of patients with kidney diseases showed plasma kidney injury molecule-1 was associated with ...

More than 800 million people globally have chronic kidney disease. The condition is a known risk factor for heart disease. Researchers from Brigham and Women’s Hospital have found that different types ...

People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company specializing in AI-powered pathology solutions, has announced the release of an AI kidney suite designed to advance research ...